Global Neuroblastoma Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neuroblastoma Treatment Market Size 2017-2028

2.1.2 Neuroblastoma Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Neuroblastoma Treatment Segment by Type

2.2.1 Combination Chemotherapy

2.2.2 Monoclonal Antibody Therapy

2.2.3 Vaccine Therapy

2.2.4 Chimeric Antigen Receptor T-Cell Immunotherapy

2.2.5 Oncolytic Virus Therapy

2.3 Neuroblastoma Treatment Market Size by Type

2.3.1 Neuroblastoma Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

2.4 Neuroblastoma Treatment Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Neuroblastoma Treatment Market Size by Application

2.5.1 Neuroblastoma Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

3 Neuroblastoma Treatment Market Size by Player

3.1 Neuroblastoma Treatment Market Size Market Share by Players

3.1.1 Global Neuroblastoma Treatment Revenue by Players (2020-2022)

3.1.2 Global Neuroblastoma Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Neuroblastoma Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Neuroblastoma Treatment by Regions

4.1 Neuroblastoma Treatment Market Size by Regions (2017-2022)

4.2 Americas Neuroblastoma Treatment Market Size Growth (2017-2022)

4.3 APAC Neuroblastoma Treatment Market Size Growth (2017-2022)

4.4 Europe Neuroblastoma Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Neuroblastoma Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Neuroblastoma Treatment Market Size by Country (2017-2022)

5.2 Americas Neuroblastoma Treatment Market Size by Type (2017-2022)

5.3 Americas Neuroblastoma Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neuroblastoma Treatment Market Size by Region (2017-2022)

6.2 APAC Neuroblastoma Treatment Market Size by Type (2017-2022)

6.3 APAC Neuroblastoma Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Neuroblastoma Treatment by Country (2017-2022)

7.2 Europe Neuroblastoma Treatment Market Size by Type (2017-2022)

7.3 Europe Neuroblastoma Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neuroblastoma Treatment by Region (2017-2022)

8.2 Middle East & Africa Neuroblastoma Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Neuroblastoma Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Neuroblastoma Treatment Market Forecast

10.1 Global Neuroblastoma Treatment Forecast by Regions (2023-2028)

10.1.1 Global Neuroblastoma Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Neuroblastoma Treatment Forecast

10.1.3 APAC Neuroblastoma Treatment Forecast

10.1.4 Europe Neuroblastoma Treatment Forecast

10.1.5 Middle East & Africa Neuroblastoma Treatment Forecast

10.2 Americas Neuroblastoma Treatment Forecast by Country (2023-2028)

10.2.1 United States Neuroblastoma Treatment Market Forecast

10.2.2 Canada Neuroblastoma Treatment Market Forecast

10.2.3 Mexico Neuroblastoma Treatment Market Forecast

10.2.4 Brazil Neuroblastoma Treatment Market Forecast

10.3 APAC Neuroblastoma Treatment Forecast by Region (2023-2028)

10.3.1 China Neuroblastoma Treatment Market Forecast

10.3.2 Japan Neuroblastoma Treatment Market Forecast

10.3.3 Korea Neuroblastoma Treatment Market Forecast

10.3.4 Southeast Asia Neuroblastoma Treatment Market Forecast

10.3.5 India Neuroblastoma Treatment Market Forecast

10.3.6 Australia Neuroblastoma Treatment Market Forecast

10.4 Europe Neuroblastoma Treatment Forecast by Country (2023-2028)

10.4.1 Germany Neuroblastoma Treatment Market Forecast

10.4.2 France Neuroblastoma Treatment Market Forecast

10.4.3 UK Neuroblastoma Treatment Market Forecast

10.4.4 Italy Neuroblastoma Treatment Market Forecast

10.4.5 Russia Neuroblastoma Treatment Market Forecast

10.5 Middle East & Africa Neuroblastoma Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Neuroblastoma Treatment Market Forecast

10.5.2 South Africa Neuroblastoma Treatment Market Forecast

10.5.3 Israel Neuroblastoma Treatment Market Forecast

10.5.4 Turkey Neuroblastoma Treatment Market Forecast

10.5.5 GCC Countries Neuroblastoma Treatment Market Forecast

10.6 Global Neuroblastoma Treatment Forecast by Type (2023-2028)

10.7 Global Neuroblastoma Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Seattle Children’s

11.1.1 Seattle Children’s Company Information

11.1.2 Seattle Children’s Neuroblastoma Treatment Product Offered

11.1.3 Seattle Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Seattle Children’s Main Business Overview

11.1.5 Seattle Children’s Latest Developments

11.2 CureSearch

11.2.1 CureSearch Company Information

11.2.2 CureSearch Neuroblastoma Treatment Product Offered

11.2.3 CureSearch Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 CureSearch Main Business Overview

11.2.5 CureSearch Latest Developments

11.3 Texas Children’s

11.3.1 Texas Children’s Company Information

11.3.2 Texas Children’s Neuroblastoma Treatment Product Offered

11.3.3 Texas Children’s Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Texas Children’s Main Business Overview

11.3.5 Texas Children’s Latest Developments

11.4 NANT

11.4.1 NANT Company Information

11.4.2 NANT Neuroblastoma Treatment Product Offered

11.4.3 NANT Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 NANT Main Business Overview

11.4.5 NANT Latest Developments

11.5 Sino Biopharmaceutical

11.5.1 Sino Biopharmaceutical Company Information

11.5.2 Sino Biopharmaceutical Neuroblastoma Treatment Product Offered

11.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sino Biopharmaceutical Main Business Overview

11.5.5 Sino Biopharmaceutical Latest Developments

11.6 Jiangsu Hengrui Medicine Co.,Ltd.

11.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Information

11.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered

11.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Main Business Overview

11.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments

11.7 Fosun Pharmaceutical

11.7.1 Fosun Pharmaceutical Company Information

11.7.2 Fosun Pharmaceutical Neuroblastoma Treatment Product Offered

11.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Fosun Pharmaceutical Main Business Overview

11.7.5 Fosun Pharmaceutical Latest Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Neuroblastoma Treatment Product Offered

11.8.3 Novartis Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Novartis Main Business Overview

11.8.5 Novartis Latest Developments

11.9 Juno Therapeutics

11.9.1 Juno Therapeutics Company Information

11.9.2 Juno Therapeutics Neuroblastoma Treatment Product Offered

11.9.3 Juno Therapeutics Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Juno Therapeutics Main Business Overview

11.9.5 Juno Therapeutics Latest Developments

11.10 Kite Pharma

11.10.1 Kite Pharma Company Information

11.10.2 Kite Pharma Neuroblastoma Treatment Product Offered

11.10.3 Kite Pharma Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Kite Pharma Main Business Overview

11.10.5 Kite Pharma Latest Developments

11.11 Adaptimmune

11.11.1 Adaptimmune Company Information

11.11.2 Adaptimmune Neuroblastoma Treatment Product Offered

11.11.3 Adaptimmune Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Adaptimmune Main Business Overview

11.11.5 Adaptimmune Latest Developments

12 Research Findings and Conclusion

Table 1. Neuroblastoma Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Combination Chemotherapy

Table 3. Major Players of Monoclonal Antibody Therapy

Table 4. Major Players of Vaccine Therapy

Table 5. Major Players of Chimeric Antigen Receptor T-Cell Immunotherapy

Table 6. Major Players of Oncolytic Virus Therapy

Table 7. Neuroblastoma Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Neuroblastoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

Table 10. Neuroblastoma Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Neuroblastoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global Neuroblastoma Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Neuroblastoma Treatment Revenue Market Share by Player (2020-2022)

Table 15. Neuroblastoma Treatment Key Players Head office and Products Offered

Table 16. Neuroblastoma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Neuroblastoma Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Neuroblastoma Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas Neuroblastoma Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Neuroblastoma Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas Neuroblastoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas Neuroblastoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC Neuroblastoma Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Neuroblastoma Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC Neuroblastoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC Neuroblastoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe Neuroblastoma Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Neuroblastoma Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe Neuroblastoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe Neuroblastoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Neuroblastoma Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Neuroblastoma Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Neuroblastoma Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Neuroblastoma Treatment

Table 46. Key Market Challenges & Risks of Neuroblastoma Treatment

Table 47. Key Industry Trends of Neuroblastoma Treatment

Table 48. Global Neuroblastoma Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Neuroblastoma Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Neuroblastoma Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Neuroblastoma Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Neuroblastoma Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Neuroblastoma Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. Seattle Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 55. Seattle Children’s Neuroblastoma Treatment Product Offered

Table 56. Seattle Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Seattle Children’s Main Business

Table 58. Seattle Children’s Latest Developments

Table 59. CureSearch Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 60. CureSearch Neuroblastoma Treatment Product Offered

Table 61. CureSearch Main Business

Table 62. CureSearch Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. CureSearch Latest Developments

Table 64. Texas Children’s Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 65. Texas Children’s Neuroblastoma Treatment Product Offered

Table 66. Texas Children’s Main Business

Table 67. Texas Children’s Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Texas Children’s Latest Developments

Table 69. NANT Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 70. NANT Neuroblastoma Treatment Product Offered

Table 71. NANT Main Business

Table 72. NANT Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. NANT Latest Developments

Table 74. Sino Biopharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 75. Sino Biopharmaceutical Neuroblastoma Treatment Product Offered

Table 76. Sino Biopharmaceutical Main Business

Table 77. Sino Biopharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Sino Biopharmaceutical Latest Developments

Table 79. Jiangsu Hengrui Medicine Co.,Ltd. Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 80. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product Offered

Table 81. Jiangsu Hengrui Medicine Co.,Ltd. Main Business

Table 82. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments

Table 84. Fosun Pharmaceutical Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 85. Fosun Pharmaceutical Neuroblastoma Treatment Product Offered

Table 86. Fosun Pharmaceutical Main Business

Table 87. Fosun Pharmaceutical Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Fosun Pharmaceutical Latest Developments

Table 89. Novartis Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 90. Novartis Neuroblastoma Treatment Product Offered

Table 91. Novartis Main Business

Table 92. Novartis Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Novartis Latest Developments

Table 94. Juno Therapeutics Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 95. Juno Therapeutics Neuroblastoma Treatment Product Offered

Table 96. Juno Therapeutics Main Business

Table 97. Juno Therapeutics Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Juno Therapeutics Latest Developments

Table 99. Kite Pharma Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 100. Kite Pharma Neuroblastoma Treatment Product Offered

Table 101. Kite Pharma Main Business

Table 102. Kite Pharma Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Kite Pharma Latest Developments

Table 104. Adaptimmune Details, Company Type, Neuroblastoma Treatment Area Served and Its Competitors

Table 105. Adaptimmune Neuroblastoma Treatment Product Offered

Table 106. Adaptimmune Neuroblastoma Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Adaptimmune Main Business

Table 108. Adaptimmune Latest Developments

List of Figures

Figure 1. Neuroblastoma Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Neuroblastoma Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Neuroblastoma Treatment Market Size Market Share by Type in 2021

Figure 7. Neuroblastoma Treatment in Hospitals

Figure 8. Global Neuroblastoma Treatment Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Neuroblastoma Treatment in Clinics

Figure 10. Global Neuroblastoma Treatment Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Neuroblastoma Treatment in Others

Figure 12. Global Neuroblastoma Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Neuroblastoma Treatment Market Size Market Share by Application in 2021

Figure 14. Global Neuroblastoma Treatment Revenue Market Share by Player in 2021

Figure 15. Global Neuroblastoma Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Neuroblastoma Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Neuroblastoma Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Neuroblastoma Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Neuroblastoma Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Neuroblastoma Treatment Value Market Share by Country in 2021

Figure 21. Americas Neuroblastoma Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Neuroblastoma Treatment Market Size Market Share by Application in 2021

Figure 23. United States Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Neuroblastoma Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Neuroblastoma Treatment Market Size Market Share by Application in 2021

Figure 29. China Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Neuroblastoma Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Neuroblastoma Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Neuroblastoma Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Neuroblastoma Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Neuroblastoma Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Neuroblastoma Treatment Market Size 2023-2028 ($ Millions)